Axsome Therapeutics AXSM
NASDAQ AXSM
$182.07 -2.32 (-1.26%)
At close: Oct 1, 2026 · 4:00 PM EDT

Axsome Therapeutics (AXSM) Liabilities and Shareholders Equity (2015 - 2026)

Updated

Axsome Therapeutics (AXSM) reported Liabilities and Shareholders Equity of $761.45 million for Q2 2026, up 19.0% from $639.79 million a year earlier and up 6.7% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends

At the end of FY2025, Axsome Therapeutics posted Liabilities and Shareholders Equity of $689.81 million, up 21.3% from FY2024.

  • Liabilities and Shareholders Equity has a five-year compound annual growth rate of 30.0% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $568.5 million in FY2024 (-3.4%), $588.24 million in FY2023 (+77.5%), $331.48 million in FY2022 (+277.6%) and $87.79 million in FY2021 (-52.8%).
  • The Q2 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2015.
  • Year over year, Liabilities and Shareholders Equity has now increased in each of the last six quarters, with growth averaging 11.9% over the last eight quarters.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q1 2023 (growth of 339.5%); the low point was Q4 2021 (a decline of 52.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $713.61 million (Q1 2026), $689.81 million (Q4 2025) and $669.25 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Axsome Therapeutics 9.64 Bn 8.37 Bn 204.81 Mn 761.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 761.45 Mn
Mar 31, 2026 713.61 Mn
Dec 31, 2025 689.81 Mn
Sep 30, 2025 669.25 Mn
Jun 30, 2025 639.79 Mn
Mar 31, 2025 596.67 Mn
Dec 31, 2024 568.50 Mn
Sep 30, 2024 561.46 Mn
Jun 30, 2024 548.23 Mn
Mar 31, 2024 545.73 Mn
Dec 31, 2023 588.24 Mn
Sep 30, 2023 600.86 Mn
Jun 30, 2023 611.64 Mn
Mar 31, 2023 389.18 Mn
Dec 31, 2022 331.48 Mn
Sep 30, 2022 338.96 Mn
Jun 30, 2022 180.56 Mn
Mar 31, 2022 88.56 Mn
Dec 31, 2021 87.79 Mn
Sep 30, 2021 116.60 Mn
API Access

Axsome Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=AXSM&period=max&api_key=YOUR_API_KEY